Symbol="FDMT"
AssetType="Common Stock"
Name="4D Molecular TherapeuticsÂ Inc"
Description="4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops candidate products using its adeno-associated virus vectors. The company is headquartered in Emeryville, California."
CIK="1650648"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="5858 HORTON STREET #455, EMERYVILLE, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="792472000"
EBITDA="-110720000"
PERatio="None"
PEGRatio="None"
BookValue="6.58"
DividendPerShare="0"
DividendYield="0"
EPS="-3.24"
RevenuePerShareTTM="0.068"
ProfitMargin="0"
OperatingMarginTTM="-51.52"
ReturnOnAssetsTTM="-0.25"
ReturnOnEquityTTM="-0.427"
RevenueTTM="2208000"
GrossProfitTTM="-77124000"
DilutedEPSTTM="-3.24"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.756"
AnalystTargetPrice="38.88"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="378.9"
PriceToBookRatio="3.014"
EVToRevenue="277.01"
EVToEBITDA="-5.32"
Beta="2.354"
num_52WeekHigh="26.49"
num_52WeekLow="6.58"
num_50DayMovingAverage="18.68"
num_200DayMovingAverage="17.61"
SharesOutstanding="41885400"
DividendDate="None"
ExDividendDate="None"
symbol="FDMT"
open="18.94"
high="19.52"
low="18.56"
price="18.58"
volume="181114.00"
latest_trading_day="2023-07-17"
previous_close="18.92"
change="-0.34"
change_percent="-1.7970%"
aroon_positive_momentum_days="24"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="24"
Volume_recent_avg="552722"
Change_recent_avg="-0.02"
Delta_recent_avg="1.34"
Variance_recent_avg="0.67"
Change_ratio_recent_avg="-0.21"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="24"
Aroon_momentum_negative="76"
image_negative_thumbnail_id_1="488"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0117.jpeg"
image_negative_thumbnail_id_2="142"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0034.jpeg"
image_neutral_thumbnail_id_1="598"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0001.jpeg"
image_neutral_thumbnail_id_2="566"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_positive_thumbnail_id_1="965"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0127.jpeg"
image_positive_thumbnail_id_2="951"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0113.jpeg"
image_professor_thumbnail_id_1="1176"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
image_professor_thumbnail_id_2="1194"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
